Workflow
Evolus(EOLS)
icon
Search documents
Evolus(EOLS) - 2020 Q3 - Quarterly Report
2020-10-29 20:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _______ ...
Evolus(EOLS) - 2020 Q2 - Earnings Call Transcript
2020-08-11 00:27
Evolus, Inc. (NASDAQ:EOLS) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Ashwin Agarwal - Vice President, Finance, Investor Relations and Treasury David Moatazedi - President and Chief Executive Officer Mike Jafar - Chief Marketing Officer Rui Avelar - Chief Medical Officer Lauren Silvernail - Chief Financial Officer and Executive Vice President, Corporate Development Jeff Plumer - Vice President of Legal Conference Call Participants Marc Goodman - SVB Leerink Louise Chen ...
Evolus(EOLS) - 2020 Q2 - Quarterly Report
2020-08-10 21:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...
Evolus(EOLS) - 2020 Q2 - Earnings Call Presentation
2020-08-10 20:39
| --- | --- | --- | |-------|------------------------------------|-------| | | | | | | | | | | evolus™ Q2 2020 Financial Appendix | | | | August 10, 2020 | | | --- | |-------------------| | | | OUR PURPOSE | | To make the | | beauty experience | | delightful and | | achievable | her | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
Evolus(EOLS) - 2020 Q1 - Earnings Call Presentation
2020-05-12 21:04
| --- | --- | |-------|-------| | | | | | | | --- | |-------------------| | | | OUR PURPOSE | | To make the | | beauty experience | | delightful and | | achievable | her | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
Evolus(EOLS) - 2020 Q1 - Earnings Call Transcript
2020-05-12 00:47
Evolus, Inc. (NASDAQ:EOLS) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Ashwin Agarwal – Vice President, Finance, Investor Relations and Treasury David Moatazedi – President and Chief Executive Officer Lauren Silvernail – Chief Financial Officer and Executive Vice President, Corporate Development Conference Call Participants Roanna Ruiz – SVB Leerink Annabel Samimy – Stifel Louise Chen – Cantor Gregg Gilbert – SunTrust Vamil Divan – Mizuho Securities Douglas Tsao – H.C. Wain ...
Evolus(EOLS) - 2020 Q1 - Quarterly Report
2020-05-11 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...
Evolus(EOLS) - 2019 Q4 - Annual Report
2020-02-25 21:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________________ FORM 10-K _____________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38381 _____________________________ EVOLUS, INC. (Exact name of registrant as speci ...
Evolus(EOLS) - 2019 Q4 - Earnings Call Transcript
2020-02-25 19:31
Evolus, Inc. (NASDAQ:EOLS) Q4 2019 Results Conference Call February 25, 2020 8:00 AM ET Company Participants Ashwin Agarwal - VP, Finance, IR and Treasury David Moatazedi - President and CEO Lauren Silvernail - CFO and EVP Corporate Development Mike Jafar - Chief Marketing Officer Conference Call Participants Rudy Li - SVB Leerink Gregg Gilbert - SunTrust Annabel Samimy - Stifel Louise Chen - Cantor Douglas Tsao - H.C. Wainwright Balaji Prasad - Barclays Vamil Divan - Mizuho Operator Ladies and gentlemen, g ...
Evolus(EOLS) - 2019 Q4 - Earnings Call Presentation
2020-02-25 15:29
| --- | --- | |-------|-------| | | | | | | | --- | |-------------------| | | | OUR PURPOSE | | To make the | | beauty experience | | delightful and | | achievable | her | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...